3Rother E, Brandl R, Baker DL, et al. Subtype-seletive antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques [J]. Circulation,2003,108(6) :741-747.
2MOOLENAAR W H. Lysophosphatidic acid,a multifunctional phospholipid messenger[J]. J Biol Chem, 1995, 270(22):12949-12952.
3RELOU I A, HACKENG C M, AKKERMAN J W, et al. Low-density lipoprotein and its effect on human blood platelets[J]. Cell Mol Life Sci,2003,60(5):961-971.
4SIESS W, ZANGL K J, ESSLER M, et al. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions[J]. Proc Natl Acad Sci U S A, 1999,96(1
5KARLINER J S.Lysophospholipids and the cardiovascular system[J]. Biochim Biophys Acta, 2002,1582(1-3):216-21.
6SMYTH S S, SCIORRA V A, SIGAL Y J, et al. Lipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activity[J]. J Biol Chem, 2003, 278(44):43214-432
7ROTHER E, BRANDL R, BAKER D L, et al. Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques[J]. Circulation,2003,108(6):741-747.
